A Phase I Trial of the IGF-1R Antibody Ganitumab (AMG 479) in Combination with Everolimus (RAD001) and Panitumumab in Patients with Advanced Cancer
IGF-1R 抗体 Ganitumab (AMG 479) 联合依维莫司 (RAD001) 和帕尼单抗治疗晚期癌症患者的 I 期临床试验
期刊:Oncologist
影响因子:4.2
doi:10.1634/theoncologist.2016-0377
Vlahovic, Gordana; Meadows, Kellen L; Hatch, Ace J; Jia, Jingquan; Nixon, Andrew B; Uronis, Hope E; Morse, Michael A; Selim, M Angelica; Crawford, Jeffrey; Riedel, Richard F; Zafar, S Yousuf; Howard, Leigh A; O'Neill, Margot; Meadows, Jennifer J; Haley, Sherri T; Arrowood, Christy C; Rushing, Christel; Pang, Herbert; Hurwitz, Herbert I